• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?

作者信息

Guillon Antoine, Reckamp Karen L, Heuzé-Vourc'h Nathalie

机构信息

CHRU de Tours, Service de Réanimation Polyvalente, F-37000, Tours, France.

INSERM, Centre d'Étude des Pathologies Respiratoires, U1100, F-37032, Tours, France.

出版信息

Crit Care. 2017 Jan 27;21(1):18. doi: 10.1186/s13054-017-1602-8.

DOI:10.1186/s13054-017-1602-8
PMID:28126007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5270208/
Abstract
摘要

相似文献

1
Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?免疫疗法改善肺癌预后：我们是否必须改变重症监护病房的收治和分诊指南？
Crit Care. 2017 Jan 27;21(1):18. doi: 10.1186/s13054-017-1602-8.
2
An observational cohort study of triage for critical care provision during pandemic influenza: 'clipboard physicians' or 'evidenced based medicine'?大流行性流感期间重症监护分诊的观察性队列研究：“剪贴板医生”还是“循证医学”？
Anaesthesia. 2009 Nov;64(11):1199-206. doi: 10.1111/j.1365-2044.2009.06084.x.
3
The Eldicus prospective, observational study of triage decision making in European intensive care units: part I--European Intensive Care Admission Triage Scores.《Eldicus 前瞻性观察研究：欧洲重症监护病房分诊决策》：第一部分——欧洲重症监护入院分诊评分。
Crit Care Med. 2012 Jan;40(1):125-31. doi: 10.1097/CCM.0b013e31822e5692.
4
Immunogenic targets in non-small cell lung cancer: more is more.非小细胞肺癌中的免疫原性靶点：越多越好。
Clin Cancer Res. 2005 Aug 1;11(15):5331-2. doi: 10.1158/1078-0432.CCR-05-0880.
5
Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine.重症监护病房收治、出院及分诊指南。美国重症医学学院、危重病医学会特别工作组
Crit Care Med. 1999 Mar;27(3):633-8.
6
Admission, discharge, and triage in critical care. Principles and practice.重症监护中的入院、出院及分诊。原则与实践。
Crit Care Clin. 1993 Jul;9(3):555-74.
7
Factors Associated with the Need for Intensive Care Unit Admission Following Supratentorial Intracerebral Hemorrhage: The Triage ICH Model.幕上脑出血后入住重症监护病房需求的相关因素：分流性脑出血模型
Neurocrit Care. 2017 Aug;27(1):75-81. doi: 10.1007/s12028-016-0346-7.
8
Intensive care units in the triage mode. An organizational perspective.分诊模式下的重症监护病房。组织视角。
Crit Care Clin. 1993 Jul;9(3):415-24.
9
Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms.肺癌的免疫检查点抑制剂治疗：新型药物、生物标志物和治疗模式。
Future Oncol. 2016 Feb;12(4):551-64. doi: 10.2217/fon.15.309. Epub 2016 Jan 18.
10
Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit.入住医学重症监护病房的肺癌患者的结局及预后因素
Eur Respir J. 2008 Jan;31(1):47-53. doi: 10.1183/09031936.00031607. Epub 2007 Aug 22.

引用本文的文献

1
Analysis of PD-1/PD-L1 variations in lung cancer and association with immunotherapeutic efficacy and prognosis: A nonrandomized controlled trial.分析肺癌中 PD-1/PD-L1 的变异与免疫治疗疗效和预后的关系：一项非随机对照试验。
Clinics (Sao Paulo). 2024 Jun 8;79:100395. doi: 10.1016/j.clinsp.2024.100395. eCollection 2024.
2
Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation.酪氨酸激酶抑制剂改善了接受机械通气的重症表皮生长因子受体突变型肺癌患者的生存率。
Biomedicines. 2021 Oct 8;9(10):1416. doi: 10.3390/biomedicines9101416.
3
Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer.粘着斑激酶（FAK）表达对三阴性乳腺癌CIK疗法细胞毒性作用的影响
Cancers (Basel). 2019 Dec 30;12(1):94. doi: 10.3390/cancers12010094.
4
Effect of intensivist involvement on clinical outcomes in patients with advanced lung cancer admitted to the intensive care unit.重症监护医师参与对入住重症监护病房的晚期肺癌患者临床结局的影响。
PLoS One. 2019 Feb 13;14(2):e0210951. doi: 10.1371/journal.pone.0210951. eCollection 2019.
5
A population-based analysis of outcomes after radiotherapy in intensive care unit patients with lung cancer.对重症监护病房肺癌患者放疗后结局的基于人群的分析。
J Thorac Dis. 2018 Mar;10(3):1440-1448. doi: 10.21037/jtd.2018.02.05.
6
Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.细胞因子诱导的杀伤细胞作为一种可行的过继免疫疗法用于治疗肺癌。
Cell Death Dis. 2018 Mar 6;9(3):366. doi: 10.1038/s41419-018-0404-5.

本文引用的文献

1
Checkpoint inhibitors in lung cancer: latest developments and clinical potential.肺癌中的检查点抑制剂：最新进展与临床潜力
Ther Adv Med Oncol. 2016 Nov;8(6):460-473. doi: 10.1177/1758834016661164. Epub 2016 Jul 26.
2
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.帕博利珠单抗对比化疗用于 PD-L1 阳性非小细胞肺癌。
N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8.
3
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.单独使用紫杉醇-卡铂或联合贝伐单抗治疗非小细胞肺癌。
N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884.